Precision medicines to match the complexity of the human brain. Backed by Third Rock Ventures.
About the role
Join our Clinical Operations team and play a key role in getting clinical studies off the ground. As a Study Start-Up Associate, you'll help drive study activation by coordinating essential start-up activities, managing critical documentation, and partnering with cross-functional teams to keep studies on track. If you're highly organized, thrive in a fast-paced environment, and enjoy bringing structure to complex projects, this is a great opportunity to make an impact from day one. Found on 1752vc Careers, the job board for startup and VC roles.
What they're looking for
- Bachelor's degree in Life Sciences, Healthcare, or a related field
- 3+ years of experience supporting clinical trials in a biotech, pharmaceutical, or CRO environment, with experience in study start-up required
- Experience supporting global, multi-center clinical trials, including site start-up and activation activities across multiple countries and regions
- Working knowledge of ICH-GCP guidelines and the clinical trial start-up process
- Experience reviewing, tracking, and maintaining essential study documents and Trial Master Files (TMFs)
- Familiarity with CTMS, eTMF, and document management systems
More about this role
When our people share why they joined Rapport and love it here, it comes down to three things: the science, the mission, and the team. At Rapport, we’re driven by a passion for developing precision neuromedicines with the potential for fewer side effects, enabling patients and their families to enjoy healthier, more fulfilling lives. And we’re doing this with extraordinary science and awesome people (affectionately called Rapptors).
Our innovative scientific platform is centered on Receptor Associate Proteins (RAPs). RAPs are a component of neuronal receptor complexes, which play a crucial role in regulating receptor assembly and function. This precision approach has the potential to revolutionize the development of small molecule therapies. We are excited about the potential of our lead program, RAP-219. Our first indication targets focal epilepsy with additional clinical trials in primary generalized tonic-clonic seizures (PGTCS) and bipolar disorder.
The strength of Rapport comes from our Rapptors – who are united by our mission to improve patients lives. We bring the heart and hustle to advance our science forward, always staying true to our core values. We hope you’re as...
Browse similar: Startup jobs